Author Correction: BCL6 enables Ph
        + acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition.: BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition (Nature, (2011), 473, 7347, (384-388), 10.1038/nature09883)

Cihangir Duy; Christian Hurtz; Seyedmehdi Shojaee; Leandro Cerchietti; Huimin Geng; Srividya Swaminathan; Lars Klemm; Soo-mi Kweon; Rahul Nahar; Melanie Braig; Eugene Park; Yong-mi Kim; Wolf-Karsten Hofmann; Sebastian Herzog; Hassan Jumaa; H. Phillip Koeffler; J. Jessica Yu; Nora Heisterkamp; Thomas G. Graeber; Hong Wu; B. Hilda Ye; Ari Melnick; Markus Muschen

doi:10.1038/s41586-026-10253-9

Author Correction: BCL6 enables Ph + acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition (Nature, (2011), 473, 7347, (384-388), 10.1038/nature09883)

Cihangir Duy
, Christian Hurtz
, Seyedmehdi Shojaee
, Leandro Cerchietti
, Huimin Geng
, Srividya Swaminathan
, Lars Klemm
, Soo-mi Kweon
, Rahul Nahar
, Melanie Braig
, Eugene Park
, Yong-mi Kim
, Wolf-Karsten Hofmann
, Sebastian Herzog
, Hassan Jumaa
, H. Phillip Koeffler
, J. Jessica Yu
, Nora Heisterkamp
, Thomas G. Graeber
, Hong Wu

B. Hilda Ye, Ari Melnick, Markus Muschen

Research output: Contribution to journal › Comment/debate

Abstract

Correction to: Naturehttps://doi.org/10.1038/nature09883 Published online 18 May 2011 In the version of this article initially published, the panel “Adriamycin/BCL6^+/+” in Fig. 2d represents another image of the “Control/BCL6^−/−” condition. The error occurred during figure assembly and did not affect the calculation of mean values and s.d. Our own image analysis, not available at the time of publication, revealed that the panel “SFO2/Imatinib” in Supplementary Fig. 21 contained an inadvertent duplication. The corrected figure panels are provided below as Figs. 1 and 2. The original raw image and flow cytometry files have been published via Mendeley Data¹. This notice serves to amend the errors. (Figure presented.) (Figure presented.).

Original language	English
Pages (from-to)	E3-E3
Number of pages	1
Journal	Nature
Volume	651
Issue number	8104
DOIs	https://doi.org/10.1038/s41586-026-10253-9
State	Published - Mar 2026

Access to Document

10.1038/s41586-026-10253-9

Fingerprint

Dive into the research topics of 'Author Correction: BCL6 enables Ph + acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition (Nature, (2011), 473, 7347, (384-388), 10.1038/nature09883)'. Together they form a unique fingerprint.

Cite this

Duy, C., Hurtz, C., Shojaee, S., Cerchietti, L., Geng, H., Swaminathan, S., Klemm, L., Kweon, S., Nahar, R., Braig, M., Park, E., Kim, Y., Hofmann, W.-K., Herzog, S., Jumaa, H., Koeffler, H. P., Yu, J. J., Heisterkamp, N., Graeber, T. G., ... Muschen, M. (2026). Author Correction: BCL6 enables Ph + acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition (Nature, (2011), 473, 7347, (384-388), 10.1038/nature09883). Nature, 651(8104), E3-E3. https://doi.org/10.1038/s41586-026-10253-9

Duy, Cihangir ; Hurtz, Christian ; Shojaee, Seyedmehdi et al. / Author Correction: BCL6 enables Ph + acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition (Nature, (2011), 473, 7347, (384-388), 10.1038/nature09883). In: Nature. 2026 ; Vol. 651, No. 8104. pp. E3-E3.

@article{6116002c29704352835a61cc0950947b,

title = "Author Correction: BCL6 enables Ph + acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition.: BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR{\textendash}ABL1 kinase inhibition (Nature, (2011), 473, 7347, (384-388), 10.1038/nature09883)",

abstract = "Correction to: Naturehttps://doi.org/10.1038/nature09883 Published online 18 May 2011 In the version of this article initially published, the panel {\textquotedblleft}Adriamycin/BCL6+/+{\textquotedblright} in Fig. 2d represents another image of the {\textquotedblleft}Control/BCL6−/−{\textquotedblright} condition. The error occurred during figure assembly and did not affect the calculation of mean values and s.d. Our own image analysis, not available at the time of publication, revealed that the panel {\textquotedblleft}SFO2/Imatinib{\textquotedblright} in Supplementary Fig. 21 contained an inadvertent duplication. The corrected figure panels are provided below as Figs. 1 and 2. The original raw image and flow cytometry files have been published via Mendeley Data1. This notice serves to amend the errors. (Figure presented.) (Figure presented.).",

author = "Cihangir Duy and Christian Hurtz and Seyedmehdi Shojaee and Leandro Cerchietti and Huimin Geng and Srividya Swaminathan and Lars Klemm and Soo-mi Kweon and Rahul Nahar and Melanie Braig and Eugene Park and Yong-mi Kim and Wolf-Karsten Hofmann and Sebastian Herzog and Hassan Jumaa and Koeffler, \{H. Phillip\} and Yu, \{J. Jessica\} and Nora Heisterkamp and Graeber, \{Thomas G.\} and Hong Wu and Ye, \{B. Hilda\} and Ari Melnick and Markus Muschen",

note = "Publisher Copyright: {\textcopyright} Springer Nature Limited 2026.",

year = "2026",

month = mar,

doi = "10.1038/s41586-026-10253-9",

language = "English",

volume = "651",

pages = "E3--E3",

journal = "Nature",

issn = "0028-0836",

publisher = "Nature Research",

number = "8104",

}

Duy, C, Hurtz, C, Shojaee, S, Cerchietti, L, Geng, H, Swaminathan, S, Klemm, L, Kweon, S, Nahar, R, Braig, M, Park, E, Kim, Y, Hofmann, W-K, Herzog, S, Jumaa, H, Koeffler, HP, Yu, JJ, Heisterkamp, N, Graeber, TG, Wu, H, Ye, BH, Melnick, A & Muschen, M 2026, 'Author Correction: BCL6 enables Ph + acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition (Nature, (2011), 473, 7347, (384-388), 10.1038/nature09883)', Nature, vol. 651, no. 8104, pp. E3-E3. https://doi.org/10.1038/s41586-026-10253-9

Author Correction: BCL6 enables Ph + acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition (Nature, (2011), 473, 7347, (384-388), 10.1038/nature09883). / Duy, Cihangir; Hurtz, Christian; Shojaee, Seyedmehdi et al.
In: Nature, Vol. 651, No. 8104, 03.2026, p. E3-E3.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Author Correction: BCL6 enables Ph + acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition.

T2 - BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition (Nature, (2011), 473, 7347, (384-388), 10.1038/nature09883)

AU - Duy, Cihangir

AU - Hurtz, Christian

AU - Shojaee, Seyedmehdi

AU - Cerchietti, Leandro

AU - Geng, Huimin

AU - Swaminathan, Srividya

AU - Klemm, Lars

AU - Kweon, Soo-mi

AU - Nahar, Rahul

AU - Braig, Melanie

AU - Park, Eugene

AU - Kim, Yong-mi

AU - Hofmann, Wolf-Karsten

AU - Herzog, Sebastian

AU - Jumaa, Hassan

AU - Koeffler, H. Phillip

AU - Yu, J. Jessica

AU - Heisterkamp, Nora

AU - Graeber, Thomas G.

AU - Wu, Hong

AU - Ye, B. Hilda

AU - Melnick, Ari

AU - Muschen, Markus

PY - 2026/3

Y1 - 2026/3

N2 - Correction to: Naturehttps://doi.org/10.1038/nature09883 Published online 18 May 2011 In the version of this article initially published, the panel “Adriamycin/BCL6+/+” in Fig. 2d represents another image of the “Control/BCL6−/−” condition. The error occurred during figure assembly and did not affect the calculation of mean values and s.d. Our own image analysis, not available at the time of publication, revealed that the panel “SFO2/Imatinib” in Supplementary Fig. 21 contained an inadvertent duplication. The corrected figure panels are provided below as Figs. 1 and 2. The original raw image and flow cytometry files have been published via Mendeley Data1. This notice serves to amend the errors. (Figure presented.) (Figure presented.).

AB - Correction to: Naturehttps://doi.org/10.1038/nature09883 Published online 18 May 2011 In the version of this article initially published, the panel “Adriamycin/BCL6+/+” in Fig. 2d represents another image of the “Control/BCL6−/−” condition. The error occurred during figure assembly and did not affect the calculation of mean values and s.d. Our own image analysis, not available at the time of publication, revealed that the panel “SFO2/Imatinib” in Supplementary Fig. 21 contained an inadvertent duplication. The corrected figure panels are provided below as Figs. 1 and 2. The original raw image and flow cytometry files have been published via Mendeley Data1. This notice serves to amend the errors. (Figure presented.) (Figure presented.).

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:001694844900001&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1038/s41586-026-10253-9

DO - 10.1038/s41586-026-10253-9

M3 - Comment/debate

C2 - 41708872

SN - 0028-0836

VL - 651

SP - E3-E3

JO - Nature

JF - Nature

IS - 8104

ER -

Duy C, Hurtz C, Shojaee S, Cerchietti L, Geng H, Swaminathan S et al. Author Correction: BCL6 enables Ph + acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition (Nature, (2011), 473, 7347, (384-388), 10.1038/nature09883). Nature. 2026 Mar;651(8104):E3-E3. doi: 10.1038/s41586-026-10253-9

Author Correction: BCL6 enables Ph + acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition (Nature, (2011), 473, 7347, (384-388), 10.1038/nature09883)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this